IP Library Granted Patent US 8,216,297
Granted Patent B2
US 8,216,297 · App. 11/504,434 · Granted Jul 10, 2012

Dual chamber cuff structure

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,216,297
App. No.
11/504,434
Granted
Jul 10, 2012
Kind
B2
Abstract

The endovascular graft includes a dual chamber cuff structure. The endovascular graft includes a tubular structure having a first end and a second end. The tubular structure has a wall defining a lumen between the first and second ends. The endovascular graft includes a cuff circumferentially secured to the tubular structure. The cuff has an interior cavity which is bifurcated such that the interior cavity includes a circumferential outer chamber and a circumferential inner chamber. The method for forming the endovascular graft includes inserting an expansion substance into the inner chamber to resist a luminal intrusion of the tubular structure resulting from the insertion of the expansion substance into the outer chamber. The expansion substance within the outer chamber is stiffened. The expansion substance within the inner chamber is removed.

Claims (17)

1. An endovascular graft comprising:

a tubular structure having a first end and a second end, said tubular structure having a wall defining a lumen between said first and second ends, said tubular structure having an outer surface and an inner surface;

a circumferential cuff, said cuff comprising an interior cavity which is bifurcated such that said interior cavity comprises a circumferential outer chamber and a circumferential inner chamber;

an elongate circumferential intermediate layer having a transverse first edge and a transverse second edge which are attached to said outer surface of said tubular structure such that said inner chamber is defined between an annular portion of said outer surface of said tubular structure and said intermediate layer; and

an elongate circumferential outer layer having a transverse first edge and a transverse second edge which are attached to an outer surface of said intermediate layer or said outer surface of said tubular structure such that said outer chamber is defined between said outer layer and said intermediate layer;

wherein said outer chamber comprises a stiffened expansion substance following completion of the implantation of the graft in a patient;

wherein said inner chamber comprises a fluid during implantation of the graft in the patient such that the inner chamber expands into the lumen, and wherein said fluid is configured to be removed from the inner chamber prior to the completion of the implantation of the graft in the patient such that the inner chamber assumes a collapsed state which results in an insubstantial or no reduction in a cross sectional area of the lumen of the tubular structure.

2. An endovascular graft according to claim 1 , said annular portion having a flexibility for radial displacement relative to an adjoining portion of said wall to provide for variation in a volume of said inner chamber.

3. An endovascular graft according to claim 1 , wherein said fluid comprises a saline solution.

4. An endovascular graft according to claim 1 , further comprising a port.

5. An endovascular graft according to claim 4 , wherein said port extends through the circumferential outer layer.

6. An endovascular graft according to claim 5 , wherein said port provides communication between said outer chamber and a conduit located external of said cuff and said tubular structure.

7. The graft of claim 4 , wherein said port extends through the annular portion.

8. An endovascular graft according to claim 7 , wherein said port provides communication between said inner chamber and a conduit which extends to a location which is external to said cuff and said tubular structure.

9. An endovascular graft according to claim 1 , wherein said expansion substance comprises a polymer.

10. An endovascular graft according to claim 1 , wherein said first end of said tubular structure defines an upstream end, said cuff being adjacent to said upstream end.

11. An endovascular graft according to claim 1 , wherein said second end of said tubular structure defines a downstream end, said cuff being adjacent to said downstream end.

Assignments (13)
SECURITY INTEREST Recorded Apr 1, 2021
From: TRIVASCULAR, INC.
To: SILICON VALLEY BANK
Reel/Frame 055794/0938 →
CHANGE OF NAME Recorded Oct 2, 2020
From: ENDOLOGIX, INC.
To: ENDOLOGIX LLC
Reel/Frame 053971/0135 →
SECURITY INTEREST Recorded Oct 2, 2020
From: ENDOLOGIX LLC (F/K/A ENDOLOGIX, INC.); NELLIX, INC.; TRIVASCULAR TECHNOLOGIES, INC.; TRIVASCULAR, INC.; TRIVASCULAR CANADA, LLC
To: DEERFIELD PRIVATE DESIGN FUND IV, L.P.
Reel/Frame 053971/0052 →
SECURITY INTEREST Recorded Aug 10, 2018
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD ELGX REVOLVER, LLC, AS AGENT
Reel/Frame 046762/0169 →
RELEASE OF SECURITY INTEREST Recorded Jan 12, 2018
From: DEERFIELD ELGX REVOLVER, LLC, AS AGENT
To: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
Reel/Frame 045059/0971 →
SECURITY INTEREST Recorded Apr 3, 2017
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT
Reel/Frame 042141/0354 →
SECURITY INTEREST Recorded Apr 3, 2017
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD ELGX REVOLVER, LLC, AS AGENT
Reel/Frame 042146/0454 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Feb 4, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: TRIVASCULAR, INC.
Reel/Frame 037701/0097 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Oct 12, 2012
From: TRIVASCULAR, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 029117/0323 →
CHANGE OF NAME Recorded Jul 13, 2010
From: TRIVASCULAR2, INC.
To: TRIVASCULAR, INC.
Reel/Frame 024672/0321 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2008
From: BOSTON SCIENTIFIC SCIMED, INC.
To: BOSTON SCIENTIFIC SANTA ROSA CORP.
Reel/Frame 021028/0179 →
CHANGE OF NAME Recorded May 30, 2008
From: BOSTON SCIENTIFIC SANTA ROSA CORP.
To: TRIVASCULAR2, INC.
Reel/Frame 021024/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2006
From: KARI, STUART E.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018182/0626 →